nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—HTR2C—metabolic syndrome X	0.718	1	CbGaD
Mirtazapine—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00871	0.106	CbGeAlD
Mirtazapine—HTR7—sympathetic nervous system—metabolic syndrome X	0.00839	0.102	CbGeAlD
Mirtazapine—HTR2A—arteriole—metabolic syndrome X	0.00821	0.1	CbGeAlD
Mirtazapine—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00585	0.0712	CbGeAlD
Mirtazapine—HTR7—autonomic nervous system—metabolic syndrome X	0.00564	0.0687	CbGeAlD
Mirtazapine—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00523	0.0637	CbGeAlD
Mirtazapine—HTR2A—autonomic nervous system—metabolic syndrome X	0.00352	0.0428	CbGeAlD
Mirtazapine—HTR7—artery—metabolic syndrome X	0.0032	0.0389	CbGeAlD
Mirtazapine—HTR7—endothelium—metabolic syndrome X	0.0027	0.0329	CbGeAlD
Mirtazapine—HTR7—blood vessel—metabolic syndrome X	0.00249	0.0303	CbGeAlD
Mirtazapine—HTR2A—artery—metabolic syndrome X	0.00199	0.0243	CbGeAlD
Mirtazapine—HTR2A—endothelium—metabolic syndrome X	0.00168	0.0205	CbGeAlD
Mirtazapine—HTR2A—blood vessel—metabolic syndrome X	0.00155	0.0189	CbGeAlD
Mirtazapine—ADRB1—cardiovascular system—metabolic syndrome X	0.00136	0.0165	CbGeAlD
Mirtazapine—HTR2B—cardiovascular system—metabolic syndrome X	0.0013	0.0158	CbGeAlD
Mirtazapine—ADRB1—adipose tissue—metabolic syndrome X	0.0012	0.0146	CbGeAlD
Mirtazapine—HTR1A—cardiovascular system—metabolic syndrome X	0.00116	0.0142	CbGeAlD
Mirtazapine—Metixene—HTR2C—metabolic syndrome X	0.00115	0.635	CrCbGaD
Mirtazapine—HTR2B—adipose tissue—metabolic syndrome X	0.00114	0.0139	CbGeAlD
Mirtazapine—HTR7—cardiovascular system—metabolic syndrome X	0.00111	0.0135	CbGeAlD
Mirtazapine—HTR7—kidney—metabolic syndrome X	0.00109	0.0132	CbGeAlD
Mirtazapine—ADRA1A—cardiovascular system—metabolic syndrome X	0.00107	0.0131	CbGeAlD
Mirtazapine—Ear pain—Metformin—metabolic syndrome X	0.00102	0.0309	CcSEcCtD
Mirtazapine—ADRA2C—kidney—metabolic syndrome X	0.001	0.0122	CbGeAlD
Mirtazapine—ADRA1A—adipose tissue—metabolic syndrome X	0.000946	0.0115	CbGeAlD
Mirtazapine—CYP2C8—kidney—metabolic syndrome X	0.000927	0.0113	CbGeAlD
Mirtazapine—ADRA2C—adipose tissue—metabolic syndrome X	0.000901	0.011	CbGeAlD
Mirtazapine—Lethargy—Metformin—metabolic syndrome X	0.000885	0.0269	CcSEcCtD
Mirtazapine—Migraine—Metformin—metabolic syndrome X	0.000854	0.026	CcSEcCtD
Mirtazapine—CYP2C9—cardiovascular system—metabolic syndrome X	0.000842	0.0102	CbGeAlD
Mirtazapine—Dehydration—Metformin—metabolic syndrome X	0.000806	0.0245	CcSEcCtD
Mirtazapine—Liver function test abnormal—Metformin—metabolic syndrome X	0.000801	0.0244	CcSEcCtD
Mirtazapine—Abdominal distension—Metformin—metabolic syndrome X	0.000755	0.023	CcSEcCtD
Mirtazapine—Influenza—Metformin—metabolic syndrome X	0.000749	0.0228	CcSEcCtD
Mirtazapine—Pancreatitis—Metformin—metabolic syndrome X	0.000735	0.0224	CcSEcCtD
Mirtazapine—HRH1—adipose tissue—metabolic syndrome X	0.000732	0.00891	CbGeAlD
Mirtazapine—Angina pectoris—Metformin—metabolic syndrome X	0.00073	0.0222	CcSEcCtD
Mirtazapine—Sweating increased—Metformin—metabolic syndrome X	0.00073	0.0222	CcSEcCtD
Mirtazapine—ADRA2A—adipose tissue—metabolic syndrome X	0.000719	0.00875	CbGeAlD
Mirtazapine—Neutropenia—Metformin—metabolic syndrome X	0.000701	0.0213	CcSEcCtD
Mirtazapine—HTR2A—cardiovascular system—metabolic syndrome X	0.000693	0.00844	CbGeAlD
Mirtazapine—HTR7—liver—metabolic syndrome X	0.000687	0.00837	CbGeAlD
Mirtazapine—HTR2A—kidney—metabolic syndrome X	0.000678	0.00826	CbGeAlD
Mirtazapine—Drowsiness—Metformin—metabolic syndrome X	0.000668	0.0203	CcSEcCtD
Mirtazapine—ADRA1A—liver—metabolic syndrome X	0.000663	0.00807	CbGeAlD
Mirtazapine—Mianserin—HTR2C—metabolic syndrome X	0.000659	0.365	CrCbGaD
Mirtazapine—Hepatobiliary disease—Metformin—metabolic syndrome X	0.000632	0.0192	CcSEcCtD
Mirtazapine—ADRA2C—liver—metabolic syndrome X	0.000632	0.00769	CbGeAlD
Mirtazapine—CYP3A4—kidney—metabolic syndrome X	0.000628	0.00764	CbGeAlD
Mirtazapine—CYP2D6—kidney—metabolic syndrome X	0.000618	0.00752	CbGeAlD
Mirtazapine—Bradycardia—Metformin—metabolic syndrome X	0.000611	0.0186	CcSEcCtD
Mirtazapine—Rhinitis—Metformin—metabolic syndrome X	0.000601	0.0183	CcSEcCtD
Mirtazapine—Hepatitis—Metformin—metabolic syndrome X	0.0006	0.0183	CcSEcCtD
Mirtazapine—Hypoaesthesia—Metformin—metabolic syndrome X	0.000597	0.0182	CcSEcCtD
Mirtazapine—Oedema peripheral—Metformin—metabolic syndrome X	0.000591	0.018	CcSEcCtD
Mirtazapine—CYP2C8—liver—metabolic syndrome X	0.000586	0.00713	CbGeAlD
Mirtazapine—Eye disorder—Metformin—metabolic syndrome X	0.000561	0.0171	CcSEcCtD
Mirtazapine—Cardiac disorder—Metformin—metabolic syndrome X	0.000557	0.0169	CcSEcCtD
Mirtazapine—CYP1A2—liver—metabolic syndrome X	0.000548	0.00667	CbGeAlD
Mirtazapine—Angiopathy—Metformin—metabolic syndrome X	0.000544	0.0166	CcSEcCtD
Mirtazapine—Chills—Metformin—metabolic syndrome X	0.000538	0.0164	CcSEcCtD
Mirtazapine—Malnutrition—Metformin—metabolic syndrome X	0.000522	0.0159	CcSEcCtD
Mirtazapine—CYP2C9—liver—metabolic syndrome X	0.00052	0.00633	CbGeAlD
Mirtazapine—Flatulence—Metformin—metabolic syndrome X	0.000515	0.0157	CcSEcCtD
Mirtazapine—Dysgeusia—Metformin—metabolic syndrome X	0.000511	0.0156	CcSEcCtD
Mirtazapine—Tremor—Metformin—metabolic syndrome X	0.000489	0.0149	CcSEcCtD
Mirtazapine—Ill-defined disorder—Metformin—metabolic syndrome X	0.000485	0.0147	CcSEcCtD
Mirtazapine—Malaise—Metformin—metabolic syndrome X	0.000471	0.0143	CcSEcCtD
Mirtazapine—Syncope—Metformin—metabolic syndrome X	0.000468	0.0143	CcSEcCtD
Mirtazapine—Palpitations—Metformin—metabolic syndrome X	0.000461	0.014	CcSEcCtD
Mirtazapine—Loss of consciousness—Metformin—metabolic syndrome X	0.000459	0.014	CcSEcCtD
Mirtazapine—Hypertension—Metformin—metabolic syndrome X	0.000451	0.0137	CcSEcCtD
Mirtazapine—Chest pain—Metformin—metabolic syndrome X	0.000445	0.0135	CcSEcCtD
Mirtazapine—Myalgia—Metformin—metabolic syndrome X	0.000445	0.0135	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.000442	0.0134	CcSEcCtD
Mirtazapine—Discomfort—Metformin—metabolic syndrome X	0.000439	0.0134	CcSEcCtD
Mirtazapine—HTR2A—liver—metabolic syndrome X	0.000429	0.00522	CbGeAlD
Mirtazapine—Oedema—Metformin—metabolic syndrome X	0.000426	0.013	CcSEcCtD
Mirtazapine—Infection—Metformin—metabolic syndrome X	0.000423	0.0129	CcSEcCtD
Mirtazapine—Shock—Metformin—metabolic syndrome X	0.000419	0.0128	CcSEcCtD
Mirtazapine—Nervous system disorder—Metformin—metabolic syndrome X	0.000418	0.0127	CcSEcCtD
Mirtazapine—Thrombocytopenia—Metformin—metabolic syndrome X	0.000417	0.0127	CcSEcCtD
Mirtazapine—Skin disorder—Metformin—metabolic syndrome X	0.000414	0.0126	CcSEcCtD
Mirtazapine—Hyperhidrosis—Metformin—metabolic syndrome X	0.000412	0.0125	CcSEcCtD
Mirtazapine—Anorexia—Metformin—metabolic syndrome X	0.000406	0.0124	CcSEcCtD
Mirtazapine—Hypotension—Metformin—metabolic syndrome X	0.000398	0.0121	CcSEcCtD
Mirtazapine—CYP3A4—liver—metabolic syndrome X	0.000397	0.00483	CbGeAlD
Mirtazapine—CYP2D6—liver—metabolic syndrome X	0.000391	0.00475	CbGeAlD
Mirtazapine—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.000388	0.0118	CcSEcCtD
Mirtazapine—Paraesthesia—Metformin—metabolic syndrome X	0.000383	0.0116	CcSEcCtD
Mirtazapine—Dyspnoea—Metformin—metabolic syndrome X	0.00038	0.0116	CcSEcCtD
Mirtazapine—Somnolence—Metformin—metabolic syndrome X	0.000379	0.0115	CcSEcCtD
Mirtazapine—Dyspepsia—Metformin—metabolic syndrome X	0.000375	0.0114	CcSEcCtD
Mirtazapine—Decreased appetite—Metformin—metabolic syndrome X	0.00037	0.0113	CcSEcCtD
Mirtazapine—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.000368	0.0112	CcSEcCtD
Mirtazapine—Fatigue—Metformin—metabolic syndrome X	0.000367	0.0112	CcSEcCtD
Mirtazapine—Constipation—Metformin—metabolic syndrome X	0.000364	0.0111	CcSEcCtD
Mirtazapine—Feeling abnormal—Metformin—metabolic syndrome X	0.000351	0.0107	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Metformin—metabolic syndrome X	0.000349	0.0106	CcSEcCtD
Mirtazapine—Urticaria—Metformin—metabolic syndrome X	0.000339	0.0103	CcSEcCtD
Mirtazapine—Abdominal pain—Metformin—metabolic syndrome X	0.000337	0.0103	CcSEcCtD
Mirtazapine—Asthenia—Metformin—metabolic syndrome X	0.000306	0.00931	CcSEcCtD
Mirtazapine—Pruritus—Metformin—metabolic syndrome X	0.000302	0.00918	CcSEcCtD
Mirtazapine—Diarrhoea—Metformin—metabolic syndrome X	0.000292	0.00887	CcSEcCtD
Mirtazapine—Dizziness—Metformin—metabolic syndrome X	0.000282	0.00858	CcSEcCtD
Mirtazapine—Vomiting—Metformin—metabolic syndrome X	0.000271	0.00825	CcSEcCtD
Mirtazapine—Rash—Metformin—metabolic syndrome X	0.000269	0.00818	CcSEcCtD
Mirtazapine—Dermatitis—Metformin—metabolic syndrome X	0.000268	0.00817	CcSEcCtD
Mirtazapine—Headache—Metformin—metabolic syndrome X	0.000267	0.00813	CcSEcCtD
Mirtazapine—Nausea—Metformin—metabolic syndrome X	0.000253	0.0077	CcSEcCtD
Mirtazapine—OPRK1—Signaling by GPCR—IL6—metabolic syndrome X	1.22e-05	7.39e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.22e-05	7.37e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.22e-05	7.37e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	1.22e-05	7.37e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	1.22e-05	7.37e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	1.22e-05	7.37e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—LEP—metabolic syndrome X	1.21e-05	7.36e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—APOE—metabolic syndrome X	1.21e-05	7.36e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	1.21e-05	7.33e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	1.21e-05	7.33e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	7.29e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.2e-05	7.29e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—IL6—metabolic syndrome X	1.2e-05	7.28e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—APOA1—metabolic syndrome X	1.2e-05	7.27e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.2e-05	7.25e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	1.19e-05	7.22e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	1.19e-05	7.22e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CD36—metabolic syndrome X	1.19e-05	7.22e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	1.19e-05	7.21e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-05	7.17e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.18e-05	7.13e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	1.18e-05	7.13e-05	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.17e-05	7.08e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.16e-05	7.05e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	7.05e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	7.01e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.16e-05	7e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.15e-05	6.99e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	1.15e-05	6.96e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.15e-05	6.94e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—INS—metabolic syndrome X	1.13e-05	6.85e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.13e-05	6.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.13e-05	6.84e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.13e-05	6.82e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—AKT1—metabolic syndrome X	1.13e-05	6.82e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.12e-05	6.81e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.12e-05	6.81e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1.12e-05	6.77e-05	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.11e-05	6.75e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.11e-05	6.73e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.11e-05	6.73e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.11e-05	6.72e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—AKT1—metabolic syndrome X	1.11e-05	6.71e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PPARA—metabolic syndrome X	1.11e-05	6.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.11e-05	6.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.11e-05	6.71e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-05	6.7e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.1e-05	6.68e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	1.1e-05	6.68e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.1e-05	6.68e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.1e-05	6.68e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-05	6.66e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	1.1e-05	6.65e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.1e-05	6.64e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.09e-05	6.63e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.09e-05	6.58e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	1.08e-05	6.56e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	1.08e-05	6.54e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.08e-05	6.53e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.08e-05	6.52e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.08e-05	6.52e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AGT—metabolic syndrome X	1.07e-05	6.5e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.07e-05	6.48e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOB—metabolic syndrome X	1.07e-05	6.47e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.06e-05	6.44e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	1.06e-05	6.44e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	1.06e-05	6.43e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.06e-05	6.4e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	6.39e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—APOE—metabolic syndrome X	1.05e-05	6.37e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	6.36e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.05e-05	6.35e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.04e-05	6.3e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	1.04e-05	6.3e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.04e-05	6.3e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—APOA1—metabolic syndrome X	1.04e-05	6.29e-05	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	1.04e-05	6.28e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—INS—metabolic syndrome X	1.04e-05	6.28e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.04e-05	6.28e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.03e-05	6.23e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.02e-05	6.2e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.02e-05	6.19e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	1.02e-05	6.19e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	1.02e-05	6.19e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	1.02e-05	6.18e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—LPL—metabolic syndrome X	1.02e-05	6.18e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.02e-05	6.17e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	1.02e-05	6.17e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	1.01e-05	6.13e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.01e-05	6.09e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	1e-05	6.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	1e-05	6.07e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—NOS3—metabolic syndrome X	9.92e-06	6.01e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	9.89e-06	5.99e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	9.87e-06	5.98e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	9.84e-06	5.96e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CD36—metabolic syndrome X	9.78e-06	5.92e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	9.7e-06	5.88e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CD36—metabolic syndrome X	9.69e-06	5.87e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GOT2—metabolic syndrome X	9.62e-06	5.83e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	9.62e-06	5.83e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TGFB1—metabolic syndrome X	9.56e-06	5.79e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.55e-06	5.78e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	9.53e-06	5.77e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	9.45e-06	5.73e-05	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	9.45e-06	5.73e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	9.42e-06	5.71e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TGFB1—metabolic syndrome X	9.41e-06	5.7e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.35e-06	5.66e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	9.3e-06	5.64e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	9.3e-06	5.64e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	9.26e-06	5.61e-05	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	9.24e-06	5.6e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PPARG—metabolic syndrome X	9.15e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	9.15e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOB—metabolic syndrome X	9.13e-06	5.53e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	9.11e-06	5.52e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	9.1e-06	5.51e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	9.09e-06	5.51e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARA—metabolic syndrome X	9.09e-06	5.51e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	9.07e-06	5.5e-05	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	9.04e-06	5.48e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	9.01e-06	5.46e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARA—metabolic syndrome X	9.01e-06	5.46e-05	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	8.99e-06	5.45e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—INS—metabolic syndrome X	8.97e-06	5.44e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	8.92e-06	5.41e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	8.9e-06	5.39e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	8.88e-06	5.38e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	8.85e-06	5.36e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AGT—metabolic syndrome X	8.8e-06	5.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	8.75e-06	5.3e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AGT—metabolic syndrome X	8.73e-06	5.29e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—LPL—metabolic syndrome X	8.72e-06	5.28e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.68e-06	5.26e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOE—metabolic syndrome X	8.62e-06	5.23e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	8.61e-06	5.22e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	8.6e-06	5.21e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	8.58e-06	5.2e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	8.57e-06	5.19e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	8.57e-06	5.19e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOE—metabolic syndrome X	8.55e-06	5.18e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOA1—metabolic syndrome X	8.53e-06	5.17e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOA1—metabolic syndrome X	8.45e-06	5.12e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	8.4e-06	5.09e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GOT1—metabolic syndrome X	8.3e-06	5.03e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GGT1—metabolic syndrome X	8.3e-06	5.03e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	8.29e-06	5.02e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CD36—metabolic syndrome X	8.28e-06	5.02e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—ALB—metabolic syndrome X	8.23e-06	4.99e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	8.21e-06	4.97e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	8.17e-06	4.95e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	8e-06	4.85e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	7.94e-06	4.81e-05	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	7.94e-06	4.81e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—NOS3—metabolic syndrome X	7.87e-06	4.77e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	7.81e-06	4.73e-05	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.81e-06	4.73e-05	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	7.79e-06	4.72e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARA—metabolic syndrome X	7.7e-06	4.67e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	7.69e-06	4.66e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	7.67e-06	4.65e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.65e-06	4.63e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	7.53e-06	4.56e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PPARG—metabolic syndrome X	7.51e-06	4.55e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AGT—metabolic syndrome X	7.46e-06	4.52e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PPARG—metabolic syndrome X	7.45e-06	4.51e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—INS—metabolic syndrome X	7.37e-06	4.46e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOE—metabolic syndrome X	7.31e-06	4.43e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—INS—metabolic syndrome X	7.3e-06	4.43e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	7.29e-06	4.42e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOA1—metabolic syndrome X	7.22e-06	4.38e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	7.21e-06	4.37e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IL6—metabolic syndrome X	7.21e-06	4.37e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—metabolic syndrome X	7.2e-06	4.36e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	7.13e-06	4.32e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.1e-06	4.31e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IL6—metabolic syndrome X	7.09e-06	4.3e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.09e-06	4.3e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	7.08e-06	4.29e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOB—metabolic syndrome X	7.05e-06	4.27e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	6.99e-06	4.24e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	6.98e-06	4.23e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.94e-06	4.21e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.94e-06	4.21e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	6.85e-06	4.15e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IL6—metabolic syndrome X	6.79e-06	4.11e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—ALB—metabolic syndrome X	6.75e-06	4.09e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	6.75e-06	4.09e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—LPL—metabolic syndrome X	6.73e-06	4.08e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—ALB—metabolic syndrome X	6.7e-06	4.06e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—AKT1—metabolic syndrome X	6.65e-06	4.03e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—AKT1—metabolic syndrome X	6.54e-06	3.97e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	6.48e-06	3.93e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—NOS3—metabolic syndrome X	6.46e-06	3.92e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.45e-06	3.91e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—NOS3—metabolic syndrome X	6.41e-06	3.88e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CD36—metabolic syndrome X	6.39e-06	3.87e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PPARG—metabolic syndrome X	6.36e-06	3.86e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	6.26e-06	3.8e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—INS—metabolic syndrome X	6.24e-06	3.78e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	6.12e-06	3.71e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IL6—metabolic syndrome X	6.03e-06	3.65e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.03e-06	3.65e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	6.01e-06	3.64e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	5.98e-06	3.62e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARA—metabolic syndrome X	5.94e-06	3.6e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	5.91e-06	3.58e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.9e-06	3.58e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	5.86e-06	3.55e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AGT—metabolic syndrome X	5.76e-06	3.49e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—ALB—metabolic syndrome X	5.72e-06	3.47e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOE—metabolic syndrome X	5.64e-06	3.42e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—AKT1—metabolic syndrome X	5.61e-06	3.4e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOA1—metabolic syndrome X	5.57e-06	3.38e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	5.56e-06	3.37e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	5.5e-06	3.33e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.48e-06	3.32e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—NOS3—metabolic syndrome X	5.47e-06	3.32e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	5.38e-06	3.26e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	5.26e-06	3.19e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	5.23e-06	3.17e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	5.09e-06	3.08e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	5.07e-06	3.07e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	5.01e-06	3.03e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	4.96e-06	3.01e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PPARG—metabolic syndrome X	4.91e-06	2.98e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	4.85e-06	2.94e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	4.82e-06	2.92e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—INS—metabolic syndrome X	4.82e-06	2.92e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	4.69e-06	2.84e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IL6—metabolic syndrome X	4.62e-06	2.8e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—AKT1—metabolic syndrome X	4.56e-06	2.76e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	4.54e-06	2.75e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IL6—metabolic syndrome X	4.53e-06	2.75e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	4.45e-06	2.69e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—ALB—metabolic syndrome X	4.42e-06	2.68e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.26e-06	2.58e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.22e-06	2.56e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.19e-06	2.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	4.18e-06	2.53e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.13e-06	2.5e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	4.1e-06	2.49e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.86e-06	2.34e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	3.81e-06	2.31e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—AKT1—metabolic syndrome X	3.62e-06	2.19e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.97e-06	1.8e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—AKT1—metabolic syndrome X	2.94e-06	1.78e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.52e-06	1.52e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.94e-06	1.18e-05	CbGpPWpGaD
